M&A Corner
Calibre Scientific Acquires AlphaScience, A German Provider of Diagnostics Products, To Expand Product Portfolio and Customer Reach in the Dach Region20 Mar 2023
Calibre Scientific is pleased to announce the acquisition of AlphaScience GmbH (“AlphaScience” or the “Company”), a diagnostics provider with headquarters... Continue Reading
|
OKYO Pharma Limited Prices $5.3 Million Offering of ADSs20 Mar 2023
OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and... Continue Reading
|
Sandoz Signs MoU to Build New Biologics Production Plant in Slovenia; To Support Increasing Global Demand For Biosimilar Medicines20 Mar 2023
Sandoz on Thursday announced that it has signed a Memorandum of Understanding (MOU) to build a new biologics production plant... Continue Reading
|
Sumitovant Biopharma Completes Acquisition of Myovant Sciences20 Mar 2023
Sumitovant Biopharma Ltd. (“Sumitovant”) and Myovant Sciences Ltd. (“Myovant”) announced today that Sumitovant has successfully completed its acquisition of Myovant... Continue Reading
|
Clarapath Acquires AI-Powered Digital Pathology Platform Crosscope13 Mar 2023
What You Should Know: – Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human... Continue Reading
|
Agilent Announces Acquisition of e-Msion, Early-stage Company Behind ECD Technology That Helps Accelerate Drug Development13 Mar 2023
Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation... Continue Reading
|
AstraZeneca Tagrisso Improves Overall Survival in Lung Cancer Patients in Phase 3 Trial13 Mar 2023
AstraZeneca (NASDAQ:AZN) said Tagrisso showed survival benefit in patients with a type of lung cancer who had undergone surgery, in... Continue Reading
|
Cardio Diagnostics up 5.5%, Enters $11.2M Financing Agreement13 Mar 2023
An artificial intelligence-powered precision cardiovascular medicine company, Cardio Diagnostics (NASDAQ:CDIO) enters securities purchase agreement with YA II PN, an investment... Continue Reading
|
InvoX Pharma Completes Acquisition of F-Star Therapeutics, Inc.13 Mar 2023
invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing... Continue Reading
|
J&J Consumer Health Spinoff Kenvue Begins Bond Sale to Fund Separation13 Mar 2023
Kenvue (KVUE), the consumer health spinoff of health care giant Johnson & Johnson (NYSE:JNJ), has begun an 8-part bond sale... Continue Reading
|